Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools IDH-mutant glioma

IDH-mutant glioma

Programs, trials, and reported response and survival for IDH-mutant glioma.

Data as of 11.07.2026

All studies

IDH1-VAC (IDH1 R132H Peptide Vaccine)

NOA-16

German Cancer Research Center · Phase 1 · Completed · Enrollment 39

NCT02454634

ArmReported safety
IDH1-vacn/r

A count stays a count. This page does not turn a count into a percent.